Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Hall Jesse Wayne exercised options for 36,375 Aclaris Therapeutics, Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 5, 2026
On May 1, 2026, Hall Jesse Wayne (Chief Medical Officer) exercised options for 36,375 Aclaris Therapeutics, Inc. shares, leaving 27,045 shares. Filed May 5, 2026 (Form 4).
- Options exercised
- 36,375 shares
- Holding after
- 27,045 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Option exercise | 36,375 | 36,375 | Direct | |
| May 1, 2026 | Common Stock | Shares withheld for tax | 9,330 | US$4.41 | 27,045 | Direct |
Source
Related
- Aclaris Therapeutics, Inc.
- Hall Jesse Wayne
- Aclaris Therapeutics, Inc. shareholders
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Sep 21, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Kolbeck Roland Wilhelm · Aug 4, 2026
- Form 4 · Schiff Andrew N · Jun 8, 2026
- Form 4 · Molineaux Christopher P. · Jun 8, 2026